Cargando…

State-of-the-art MR Imaging for Thoracic Diseases

Since thoracic MR imaging was first used in a clinical setting, it has been suggested that MR imaging has limited clinical utility for thoracic diseases, especially lung diseases, in comparison with x-ray CT and positron emission tomography (PET)/CT. However, in many countries and states and for spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yumi, Ohno, Yoshiharu, Hanamatsu, Satomu, Obama, Yuki, Ueda, Takahiro, Ikeda, Hirotaka, Iwase, Akiyoshi, Fukuba, Takashi, Hattori, Hidekazu, Murayama, Kazuhiro, Yoshikawa, Takeshi, Takenaka, Daisuke, Koyama, Hisanobu, Toyama, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Magnetic Resonance in Medicine 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199970/
https://www.ncbi.nlm.nih.gov/pubmed/33952785
http://dx.doi.org/10.2463/mrms.rev.2020-0184
_version_ 1784727960871239680
author Tanaka, Yumi
Ohno, Yoshiharu
Hanamatsu, Satomu
Obama, Yuki
Ueda, Takahiro
Ikeda, Hirotaka
Iwase, Akiyoshi
Fukuba, Takashi
Hattori, Hidekazu
Murayama, Kazuhiro
Yoshikawa, Takeshi
Takenaka, Daisuke
Koyama, Hisanobu
Toyama, Hiroshi
author_facet Tanaka, Yumi
Ohno, Yoshiharu
Hanamatsu, Satomu
Obama, Yuki
Ueda, Takahiro
Ikeda, Hirotaka
Iwase, Akiyoshi
Fukuba, Takashi
Hattori, Hidekazu
Murayama, Kazuhiro
Yoshikawa, Takeshi
Takenaka, Daisuke
Koyama, Hisanobu
Toyama, Hiroshi
author_sort Tanaka, Yumi
collection PubMed
description Since thoracic MR imaging was first used in a clinical setting, it has been suggested that MR imaging has limited clinical utility for thoracic diseases, especially lung diseases, in comparison with x-ray CT and positron emission tomography (PET)/CT. However, in many countries and states and for specific indications, MR imaging has recently become practicable. In addition, recently developed pulmonary MR imaging with ultra-short TE (UTE) and zero TE (ZTE) has enhanced the utility of MR imaging for thoracic diseases in routine clinical practice. Furthermore, MR imaging has been introduced as being capable of assessing pulmonary function. It should be borne in mind, however, that these applications have so far been academically and clinically used only for healthy volunteers, but not for patients with various pulmonary diseases in Japan or other countries. In 2020, the Fleischner Society published a new report, which provides consensus expert opinions regarding appropriate clinical indications of pulmonary MR imaging for not only oncologic but also pulmonary diseases. This review article presents a brief history of MR imaging for thoracic diseases regarding its technical aspects and major clinical indications in Japan 1) in terms of what is currently available, 2) promising but requiring further validation or evaluation, and 3) developments warranting research investigations in preclinical or patient studies. State-of-the-art MR imaging can non-invasively visualize lung structural and functional abnormalities without ionizing radiation and thus provide an alternative to CT. MR imaging is considered as a tool for providing unique information. Moreover, prospective, randomized, and multi-center trials should be conducted to directly compare MR imaging with conventional methods to determine whether the former has equal or superior clinical relevance. The results of these trials together with continued improvements are expected to update or modify recommendations for the use of MRI in near future.
format Online
Article
Text
id pubmed-9199970
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Japanese Society for Magnetic Resonance in Medicine
record_format MEDLINE/PubMed
spelling pubmed-91999702022-07-06 State-of-the-art MR Imaging for Thoracic Diseases Tanaka, Yumi Ohno, Yoshiharu Hanamatsu, Satomu Obama, Yuki Ueda, Takahiro Ikeda, Hirotaka Iwase, Akiyoshi Fukuba, Takashi Hattori, Hidekazu Murayama, Kazuhiro Yoshikawa, Takeshi Takenaka, Daisuke Koyama, Hisanobu Toyama, Hiroshi Magn Reson Med Sci Review Since thoracic MR imaging was first used in a clinical setting, it has been suggested that MR imaging has limited clinical utility for thoracic diseases, especially lung diseases, in comparison with x-ray CT and positron emission tomography (PET)/CT. However, in many countries and states and for specific indications, MR imaging has recently become practicable. In addition, recently developed pulmonary MR imaging with ultra-short TE (UTE) and zero TE (ZTE) has enhanced the utility of MR imaging for thoracic diseases in routine clinical practice. Furthermore, MR imaging has been introduced as being capable of assessing pulmonary function. It should be borne in mind, however, that these applications have so far been academically and clinically used only for healthy volunteers, but not for patients with various pulmonary diseases in Japan or other countries. In 2020, the Fleischner Society published a new report, which provides consensus expert opinions regarding appropriate clinical indications of pulmonary MR imaging for not only oncologic but also pulmonary diseases. This review article presents a brief history of MR imaging for thoracic diseases regarding its technical aspects and major clinical indications in Japan 1) in terms of what is currently available, 2) promising but requiring further validation or evaluation, and 3) developments warranting research investigations in preclinical or patient studies. State-of-the-art MR imaging can non-invasively visualize lung structural and functional abnormalities without ionizing radiation and thus provide an alternative to CT. MR imaging is considered as a tool for providing unique information. Moreover, prospective, randomized, and multi-center trials should be conducted to directly compare MR imaging with conventional methods to determine whether the former has equal or superior clinical relevance. The results of these trials together with continued improvements are expected to update or modify recommendations for the use of MRI in near future. Japanese Society for Magnetic Resonance in Medicine 2021-04-19 /pmc/articles/PMC9199970/ /pubmed/33952785 http://dx.doi.org/10.2463/mrms.rev.2020-0184 Text en ©2021 Japanese Society for Magnetic Resonance in Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Review
Tanaka, Yumi
Ohno, Yoshiharu
Hanamatsu, Satomu
Obama, Yuki
Ueda, Takahiro
Ikeda, Hirotaka
Iwase, Akiyoshi
Fukuba, Takashi
Hattori, Hidekazu
Murayama, Kazuhiro
Yoshikawa, Takeshi
Takenaka, Daisuke
Koyama, Hisanobu
Toyama, Hiroshi
State-of-the-art MR Imaging for Thoracic Diseases
title State-of-the-art MR Imaging for Thoracic Diseases
title_full State-of-the-art MR Imaging for Thoracic Diseases
title_fullStr State-of-the-art MR Imaging for Thoracic Diseases
title_full_unstemmed State-of-the-art MR Imaging for Thoracic Diseases
title_short State-of-the-art MR Imaging for Thoracic Diseases
title_sort state-of-the-art mr imaging for thoracic diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199970/
https://www.ncbi.nlm.nih.gov/pubmed/33952785
http://dx.doi.org/10.2463/mrms.rev.2020-0184
work_keys_str_mv AT tanakayumi stateoftheartmrimagingforthoracicdiseases
AT ohnoyoshiharu stateoftheartmrimagingforthoracicdiseases
AT hanamatsusatomu stateoftheartmrimagingforthoracicdiseases
AT obamayuki stateoftheartmrimagingforthoracicdiseases
AT uedatakahiro stateoftheartmrimagingforthoracicdiseases
AT ikedahirotaka stateoftheartmrimagingforthoracicdiseases
AT iwaseakiyoshi stateoftheartmrimagingforthoracicdiseases
AT fukubatakashi stateoftheartmrimagingforthoracicdiseases
AT hattorihidekazu stateoftheartmrimagingforthoracicdiseases
AT murayamakazuhiro stateoftheartmrimagingforthoracicdiseases
AT yoshikawatakeshi stateoftheartmrimagingforthoracicdiseases
AT takenakadaisuke stateoftheartmrimagingforthoracicdiseases
AT koyamahisanobu stateoftheartmrimagingforthoracicdiseases
AT toyamahiroshi stateoftheartmrimagingforthoracicdiseases